42 results
8-K
AUPH
Aurinia Pharmaceuticals Inc
29 Feb 24
Departure of Directors or Certain Officers
4:10pm
relationship with Dr. Volker Knappertz. Aurinia anticipates that it will provide Dr. Knappertz with a severance package substantially as set out in his
PX14A6G
emzdw4ita
26 Apr 23
Letter to shareholders
10:20am
DEF 14A
2k3stkdr06ka2
10 May 21
Definitive proxy
4:06pm
PRE 14A
jwxzkz65mgng7tj5
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-99.2
d2yd422dq9ncd0vk cip
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
EX-99.3
cvvu5p7gxl mit8n
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
8-K
EX-99.4
xxq9 1sfmqxnjtw
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
chjtr15gkd x6egw
24 Feb 21
Annual report
4:09pm
8-K
EX-99.2
13d2xlu881ow
25 Jan 21
Financial Statements and Exhibits
8:21am